Mito-TEMPO (MT) is a mitochondrial-targeted superoxide dismutase mimetic that protects the early stages of acetaminophen (APAP) hepatotoxicity by inhibiting the formation of peroxynitrite. Mito-TEMPO treatment inhibits APAP-induced EXPRESSION OF RIP3 kinase.
Mito-TEMPO (MT) is a mitochondrial-targeted superoxide dismutase mimetic that protects the early stages of acetaminophen (APAP) hepatotoxicity by inhibiting the formation of peroxynitrite. Mito-TEMPO treatment inhibits APAP-induced EXPRESSION OF RIP3 kinase.
2-Chloroacetamide is a preservative that is a herbicide for drylands and paddy fields. 2-Chloroacetamide is a fungicide in agriculture, glue, paints and coatings. 2-Chloroacetamide inhibits ultra-long chain fatty acid extending enzymes.
SRT 1720 is a potent activator of the human SIRT1, EC1.5 The value is 0.16 μM and simultaneously inhibits SIRT2 and SIRT3, EC1.5 The values are 37 μM and > 300 μM, respectively.
CPI-1189 (REN 1654, REN 1189) is an inhibitor of tumor necrosis factor (TNF) alpha. CPI-1189 inhibits the phosphorylation activation of protein kinase activated by p38 mitogens in cells and plays a neuroprotective role.
CPI-1189 (REN 1654, REN 1189) is an inhibitor of tumor necrosis factor (TNF) alpha. CPI-1189 inhibits the phosphorylation activation of protein kinase activated by p38 mitogens in cells and plays a neuroprotective role.
Fei-46 is a quinoline-based radiotracer targeting fibroblast activating protein (FAP). Fei-46 has a higher tumor absorption rate and increased tumor accumulation time. Fei-46 can be used for tumor imaging in a variety of different cancers.
Fei-46 is a quinoline-based radiotracer targeting fibroblast activating protein (FAP). Fei-46 has a higher tumor absorption rate and increased tumor accumulation time. Fei-46 can be used for tumor imaging in a variety of different cancers.
Mezigdomide (CC-92480) is a novel protein reducing agent and cereblon E3 ligase modulator (CELMoD). Mezigdomide has a strong affinity with Cereblon and has anti-myeloma activity.
Feiapi-4 is a fibroblast activating protein (FAP) inhibitor that can be used in cancer research.
Vasopressin is a cyclic nine-peptide synthesized in the hypothalamus center. Vasopressin participates in the hypothalamic-pituitary-adrenal axis and regulates pituitary corticotropin secretion by enhancing the stimulating effect of corticotropin-releasing factor. Vasopressin can also act as a neurotransmitter, acting by binding to specific...